Patent Ductus Arteriosus Stent Versus Surgical Aortopulmonary Shunt for Initial Palliation of Cyanotic Congenital Heart Disease with Ductal‐Dependent Pulmonary Blood Flow: A Systematic Review and Meta‐Analysis

Author:

Tseng Stephanie Y.12ORCID,Truong Vien T.3,Peck Daniel2,Kandi Sneha4ORCID,Brayer Samuel2ORCID,Jason Don P.5ORCID,Mazur Wojciech3,Hill Garick D.26ORCID,Ashfaq Awais7,Goldstein Bryan H.8ORCID,Alsaied Tarek8ORCID

Affiliation:

1. The Heart Center Nationwide Children’s Hospital Columbus OH

2. The Heart Institute, Cincinnati Children’s Hospital Medical Center Cincinnati OH

3. The Christ Hospital Health Network Cincinnati OH

4. Northeast Ohio Medical University Rootstown OH

5. University of Cincinnati College of Medicine Cincinnati OH

6. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH

7. Heart Institute Johns Hopkins All Children’s Hospital St. Petersburg FL

8. The Heart Institute, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine Pittsburgh PA

Abstract

Background In patients with ductal‐dependent pulmonary blood flow, initial palliation includes catheter‐based patent ductus arteriosus (PDA) stent or surgical aortopulmonary shunt (APS). This meta‐analysis aimed to compare outcomes between PDA stent and APS. Methods and Results A comprehensive literature search yielded six retrospective observational studies. Pooled adjusted hazard ratios (HR) were included to control for covariates and assess time to event analysis. Of 757 patients, 243 (32.1%) underwent PDA stent and 514 (67.9%) underwent APS. Pulmonary atresia with intact ventricular septum and expected biventricular repair were more common with PDA stent compared with APS (39.6% versus 21.2%, P <0.001 and 57.9% versus 46.6%, P =0.007, respectively). There was no statistically significant difference in mortality between PDA stent and APS (HR, 0.71; [95% CI, 0.26–1.93]; P =0.50). PDA stent was associated with lower risk of postprocedural complications (odds ratio [OR], 0.45; [95% CI, 0.25–0.81]; P =0.008), mechanical circulatory support (OR, 0.27; [95% CI, 0.09–0.79]; P =0.02), and shorter intensive care unit length of stay (−4.03 days; [95% CI, −5.99 to −2.07]; P <0.001), hospital length of stay (−5.54 days; [95% CI, −9.20 to −1.88]; P =0.003), and duration of mechanical ventilation (−3.41 days; [95% CI, −5.29 to −1.52]; P <0.001). There was no difference in pulmonary artery growth or hazard of unplanned reintereventions. Conclusions PDA stent has a similar hazard of mortality compared with APS. Benefits to PDA stent include shorter duration of mechanical ventilation, shorter hospital length of stay, and fewer complications. Differences in patient characteristics exist with more patients with pulmonary atresia with intact ventricular septum and expected biventricular repair undergoing PDA stent.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3